page banner

HapOnco®

LungCDx EGFR/ALK NGS Testing Kit

HapOnco® LungCDx EGFR/ALK NGS Testing Kit

dna

Product Overview

HapOnco® LungCDx EGFR/ALK NGS Testing Kit is an NGS-based therapy selection IVD candidate for NSCLC patients. This product was registered as a Class III medical device (国械注准20213400832) with the NMPA in October 2021. HapOnco® LungCDx detects EGFR/ALK gene mutations and has an industry-leading mutation LoD as low as 0.5% VAF, to identify patients eligible for treatment with multiple targeted therapies.

dna

Product Information

产品概况
dna

Product Performance

产品性能
dna

Product Advantages

HapOnco® LungCDx EGFR/ALK NGS Testing Kit is HaploX's NGS-based therapy selection IVD product for NSCLC with an industry-leading mutation LoD. It provides advanced companion diagnostics for cancer patients, further advancing precision medicine.

产品优势
dna

Mutations Detection

检测突变类型
contact us